Session Abstract – PMWC 2018 Silicon Valley
Session Synopsis: It is critically important that we all aim for the best possible outcome of care at the lowest possible cost. Value-based healthcare matters to both patients and providers. Value-based healthcare models have the potential to overturn traditional patient care models. Yet, the industry is facing challenges when implementing this new approach. To better understand how other countries are progressing towards value-based healthcare we have a planned a session with a series of global representatives that will discuss their learnings.
Session Chair Profile
R. Adams Dudley is professor of medicine and health policy at the University of California, San Francisco (UCSF) and associate director for research at the Philip R. Lee Institute for Health Policy Studies at UCSF. His major research interests include developing measures of quality of care and resource utilization and assessing the impact of value-based purchasing by employers and health plans. He has served as a consultant to the Institute of Medicine, the Joint Commission, the World Health Organization, General Motors, the Leapfrog Group and other large employers, and many medical societies. Mr.Dudley leads several ongoing projects to measure and reward higher quality of care, including randomized trials of pay-for-performance incentives and programs to assess the appropriateness of high cost procedures. In addition, the California Hospital Assessment and Reporting Task Force (CHART), which he founded and leads, has convened representatives of consumers, purchasers, health plans, and hospitals in California to establish a consensus, universal, robust hospital performance reporting system. The award-winning CHART web site, was designated in 2009 as the best hospital public reporting program in the country by the Center for Studying Health Change. He also authored the Agency for Healthcare Research and Quality’s recent Decision Guide on Pay-for-Performance and its Decision Guide on Consumer Incentives. He has been elected to the American Society for Clinical Investigation and, in 2005, received the Robert Wood Johnson Foundation Investigator Award in Health Policy Research.
Ph.D., Founder & Chief Scientific Officer, CEPIMP Genomics Argentina
Dr. López-Díaz specializes in the molecular biology of cancer and is a pioneer in clinical genomics implementation and education in Latin America. With a Clinical Biochemistry degree and a PhD in Chemical Sciences from National University of Córdoba- Argentina, in 2005 he moved to The Salk Institute, La Jolla, for his postdoctoral training. There, he developed a cancer research program making groundbreaking contributions to the field. A Salk Staff Scientist since 2013, he participates at the UCSD Cancer Center Molecular Tumor Board since 2014. In 2015, he became Adjunct Professor for the Master in Advanced Therapies at Universidad Francisco de Vitoria, Spain. Recipient of multiple distinctions, has given dozens of lectures worldwide and is member of ASCO, ACMG, AACR and AAAS.
M.D., Head, Medicine community division, Clalit Health Services, Israel
Dr. Lieberman leads the medical policy of Clalit in the community. He was a member of the Israeli national basket committee. His fields of interest include personalized medicine (especially in oncology), Diabetes & Gestational Diabetes management, perinatology, cardiology, pharmacoeconomics, and in general, creating and implementing heath programs in the community. In the past, Dr. Lieberman was deputy director of a large regional general hospital, and later Medical Director of the Sharon-Shomron District in Clalit Medical Services. He introduced models of risk management, quality assurance, and disease management in the district.